Prodrome (pre-headache phase) Migraine

RESEARCH STUDY CURRENTLY ENROLLING
call 757-591-8100

Prodrome (pre-headache phase) Migraine

Males and Females 18 years and older

The trial is being conducted to determine the safety and effectiveness of the medication UBRELVY in the possible treatment of pre-headache phase of migraine attacks.

Eligibility
  • 2-8 migraine days a month
  • Be able to recognize the signs that a migraine will occur in the next few hours
  • Must be able to distinguish migraine attacks from tension/cluster headaches
  • Must use 2 acceptable methods of contraception to avoid pregnancy throughout the study
Trial Duration

The trial will last up to 4 months involving 4 visits to our office

Compensation

You will be paid via Greenphire debit card.

Apply for this Study & take the first step towards better care for yourself today.

  • MM slash DD slash YYYY